Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View

Dr. Matthew Kurian

Breast Oncology · St Elizabeth Healthcare

View

Dr. Sarah Premji

Breast Oncology

View

Dr. Roberto Leon-Ferre

Breast Oncology · Mayo Clinic College of Medicine

View

Dr. Nerea Lopetegui-Lia

Breast Oncology · OSUMC

View

Dr. Allison Kurian

Breast Oncology · SU

View

Dr. Minhtri Nguyen

Breast Oncology · Advisor

View

Dr. Neil Iyengar

Breast Oncology · Emory University

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    RBDr. Robert Bast
    Leading Voice

    Dr. Robert Bast

    Medical Oncology · Breast Oncology
    The University of Texas MD Anderson Cancer Center
    robertbast
    Houston, TX, USA

    Robert C. Bast Jr., MD, is a physician-scientist in medical oncology with a focus on translational research in women’s oncology. He is a Professor of Medicine in the Department of Experimental Therapeutics at The University of Texas MD Anderson Cancer Center, where he also serves as Director of Translational Research Career Development in the Division of Cancer Medicine and holds the Harry Carothers Wiess Distinguished University Chair for Cancer Research. He is also a faculty member at the UTHealth Graduate School of Biomedical Sciences. His clinical work centers on gynecologic and breast medical oncology, biomarker-informed patient management, and bringing laboratory discoveries into clinical application. His research interests include biomarker-based early detection and prevention strategies, tumor dormancy and autophagy with broader cell-stress biology, and approaches to overcome therapeutic resistance through mechanistic studies of cell growth and metabolism. Dr. Bast’s leadership includes serving as Vice President for Translational Research and Head of the Division of Medicine at MD Anderson, as well as Director of the Duke Comprehensive Cancer Center. He is widely recognized for helping advance a monoclonal antibody discovery that enabled the CA125 blood test, and for his mentorship of physician-scientists and clinical investigators. His honors include the AACR Daniel D. Von Hoff Award, Giants of Cancer Care Award, NCI Champion and Changemaker Award, Society of Gynecologic Oncology Innovator Award, Ovarcome Pioneer Award, Rosalind Franklin Award, and MD Anderson’s LeMaistre Outstanding Achievement Award. He earned his MD, magna cum laude, from Harvard Medical School and completed an internal medicine internship at Johns Hopkins Hospital, Residency at Brigham and Womens and Fellowship at Dana Farber Cancer Institute with additional research training at Massachusetts General Hospital and the National Cancer Institute.

    Work experience

    • The University of Texas MD Anderson Cancer Center

      The University of Texas MD Anderson Cancer Center

      Professor

      1994 – present

    Education & training

    • Harvard University

      Harvard University

      Medical School

      1965 – 1971

    • Johns Hopkins Hospital

      Johns Hopkins Hospital

      Residency

      1971 – 1972

    • Massachusetts General Hospital

      Massachusetts General Hospital

      Fellowship

      1967 – 1969